‹ All stocks

NewcelX Ltd.

NCEL · NASDAQ · Healthcare

$2.86

▼ $0.05 (-1.72%)

1D 7D 1M 3M 1Y All

Day range

$2.82 – $2.86

Year range

$1.83 – $13.60

Open

$2.82

Previous close

$2.91

Market cap

$1.29M

Volume (24h)

$4.1K

Volume (52w)

$11.69K

Performance

▼ -3.70%

▼ -12.00%

▼ -32.39%

▲ 36.84%

▼ -78.00%

YTD

▲ 36.84%

▼ -78.00%

All-time

▼ -78.00%

Key statistics

P/E ratio

-0.08

EPS (TTM)

$-36.04

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

450.0K

About NewcelX Ltd.

NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1143.12	-0.59%
JNJ Johnson & Johnson	$252.93	-2.22%
ABBV AbbVie	$265.76	2.20%
MRK Merck & Co.	$139.54	-2.97%
UNH UnitedHealth Group Incorp…	$378.58	3.66%